Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes

Molecular Therapy

Volumn 9, Issue 6, 2004, Pages 837-845

  Furgeson, Darin Y ^a   Yockman, James W ^a   Janat, Margit Maria ^a   Kim, Sung Wan ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Biodistribution; Cholesterol; Cytokine; Interleukin 12; PEI; Polyethylenimine; Pulmonary metastases; Renca; Subcutaneous tumors

Indexed keywords

CHOLESTEROL; DRUG CARRIER; INTERLEUKIN 12; PLASMID DNA; POLYETHYLENEIMINE; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG TARGETING; FEMALE; GENETIC CODE; GEOMETRY; IN VITRO STUDY; KIDNEY CARCINOMA; LINEAR SYSTEM; LUNG METASTASIS; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; SKIN TUMOR; STATISTICAL SIGNIFICANCE; TUMOR REGRESSION; WEIGHT GAIN;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CHOLESTEROL; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INTERLEUKIN-12; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; POLYETHYLENEIMINE; SKIN NEOPLASMS; TISSUE DISTRIBUTION;

MURINAE;

EID: 3042858653     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.02.014     Document Type: Article

References (38)

1. http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf
2. Chakrabarty A. Hillman G.G. Maughan R.L. Visscher D.W. Ali E. Pontes J.E. Haas G.P. Influence of tumor site on the therapy of murine kidney cancer Anticancer Res. 14 1994 373-378
3. Younes E. Haas G.P. Dezso B. Ali E. Maughan R.L. Kukuruga M.A. Montecillo E. Pontes J.E. Hillman G.G. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma Cell. Immunol. 165 1995 243-251
4. Goodson R.J. Katre N.V. Site-directed pegylation of recombinant interleukin-2 at its glycosylation site Biotechnology. (N. Y) 8 1990 343-346
5. Lu Y.A. Felix A.M. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides Int. J. Pept. Protein Res. 43 1994 127-138
6. Shih Y. Konrad M.W. Warren M.K. Childs A. Paradise C. Meyers F.J. Groves E.S. Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2 Eur. J. Immunol. 22 1992 727-733
7. Hillman G.G. Younes E. Visscher D. Ali E. Lam J.S. Montecillo E. Pontes J.E. Haas G.P. Puri R.K. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model Cell. Immunol. 160 1995 257-263
8. Hillman G.G. Younes E. Visscher D. Hamzavi F. Kim S. Lam J.S. Montecillo E.J. Ali E. Pontes J.E. Puri R.K. Haas G.P. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4 Clin. Cancer Res. 3 1997 1799-1806
9. Schmidt M. Maurer-Gebhard M. Groner B. Kohler G. Brochmann-Santos G. Wels W. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors Oncogene 18 1999 1711-1721
10. Komschlies K.L. Gregorio T.A. Gruys M.E. Back T.C. Faltynek C.R. Wiltrout R.H. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases J. Immunol. 152 1994 5776-5784
11. Seki N. Brooks A.D. Carter C.R. Back T.C. Parsoneault E.M. Smyth M.J. Wiltrout R.H. Sayers T.J. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin J. Immunol. 168 2002 3484-3492
12. Koshkina N.V. Waldrep J.C. Roberts L.E. Golunski E. Melton S. Knight V. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model Clin. Cancer Res. 7 2001 3258-3262
13. Salup R.R. Sicker D.C. Wolmark N. Herberman R.B. Hakala T.R. Chemoimmunotherapy of metastatic murine renal cell carcinoma using flavone acetic acid and interleukin 2 J. Urol. 147 1992 1120-1123
14. Dezso B. Haas G.P. Hamzavi F. Kim S. Montecillo E.J. Benson P.D. Pontes J.E. Maughan R.L. Hillman G.G. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases Clin. Cancer Res. 2 1996 1543-1552
15. Hornung R.L. Back T.C. Zaharko D.S. Urba W.J. Longo D.L. Wiltrout R.H. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2 J. Immunol. 141 1988 3671-3679
16. Kobayashi M. Fitz L. Ryan M. Hewick R.M. Clark S.C. Chan S. Loudon R. Sherman F. Perussia B. Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J. Exp. Med. 170 1989 827-845
17. Podlaski F.J. Nanduri V.B. Hulmes J.D. Pan Y.C. Levin W. Danho W. Chizzonite R. Gately M.K. Stern A.S. Molecular characterization of interleukin 12 Arch Biochem Biophys 294 1992 230-237
18. Furgeson D.Y. Chan W. Yockman J.W. Kim S.W. Modified linear PEI-cholesterol conjugates for DNA complexation Bioconjug. Chem. 14 2003 840-847
19. Brunda M.J. Luistro L. Warrier R.R. Wright R.B. Hubbard B.R. Murphy M. Wolf S.F. Gately M.K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors J. Exp. Med. 178 1993 1223-1230
20. Nastala C.L. Edington H.D. McKinney T.G. Tahara H. Nalesnik M.A. Brunda M.J. Gately M.K. Wolf S.F. Schreiber R.D. Storkus W.J. et al. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production J. Immunol. 153 1994 1697-1706
21. Nomura T. Yasuda K. Yamada T. Okamoto S. Mahato R.I. Watanabe Y. Takakura Y. Hashida M. Gene expression and antitumor effects following direct interferon (IFN)- gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice Gene Ther. 6 1999 121-129
22. Trinchieri G. Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions Res. Immunol. 146 1995 423-431
23. Tannenbaum C.S. Wicker N. Armstrong D. Tubbs R. Finke J. Bukowski R.M. Hamilton T.A. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12 J. Immunol. 156 1996 693-699
24. Godbey W.T. Wu K.K. Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery Proc Natl Acad Sci U S A 96 1999 5177-5181
25. Zou S.M. Erbacher P. Remy J.S. Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse J. Gene Med. 2 2000 128-134
26. Wightman L. Kircheis R. Rossler V. Carotta S. Ruzicka R. Kursa M. Wagner E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo J. Gene Med. 3 2001 362-372
27. Furgeson D.Y. (2003). Structural and functional effects of polyethylenimine gene carriers. PhD Dissertation in Pharmaceutics and Pharmaceutical Chemistry. University of Utah: Salt Lake City.
28. Yockman J.W. Maheshwari A. Han S. Kim S.W. Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes J. Control. Release 87 2003 177-186
29. Maeda H. Wu J. Sawa T. Matsumura Y. Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271-284
30. Matsumura Y. Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387-6392
31. Kratz F. Warnecke A. Scheuermann K. Stockmar C. Schwab J. Lazar P. Druckes P. Esser N. Drevs J. Rognan D. Bissantz C. Hinderling C. Folkers G. Fichtner I. Unger C. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound J. Med. Chem. 45 2002 5523-5533
32. Kato Y. Onishi H. Machida Y. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates Biomaterials 25 2004 907-915
33. Furgeson D.Y. Yockman J.W. Mahato R.I. Kim S.W. Biodistribution of labeled water insoluble lipoparticulates (ISLP) and plasmid DNA after murine tail vein injection Controlled Release Society 2002 Seoul, South Korea
34. Furgeson D.Y. Cohen R.N. Mahato R.I. Kim S.W. Novel water insoluble lipoparticulates for gene delivery Pharm. Res. 19 2002 382-390
35. Kircheis R. Wightman L. Schreiber A. Robitza B. Rossler V. Kursa M. Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application Gene Ther. 8 2001 28-40
36. Zabner J. Fasbender A.J. Moninger T. Poellinger K.A. Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid J. Biol. Chem. 270 1995 18997-19007
37. Coll J.L. Chollet P. Brambilla E. Desplanques D. Behr J.P. Favrot M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine Hum. Gene Ther. 10 1999 1659-1666
38. Nakashima Y. Yano M. Kobayashi Y. Moriyama S. Sasaki H. Toyama T. Yamashita H. Fukai I. Iwase H. Yamakawa Y. Fujii Y. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery Gene Ther. 10 2003 123-130